300 related articles for article (PubMed ID: 15383331)
1. VE-cadherin increases the half-life of VEGF receptor 2.
Calera MR; Venkatakrishnan A; Kazlauskas A
Exp Cell Res; 2004 Oct; 300(1):248-56. PubMed ID: 15383331
[TBL] [Abstract][Full Text] [Related]
2. IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis.
Yamaoka-Tojo M; Tojo T; Kim HW; Hilenski L; Patrushev NA; Zhang L; Fukai T; Ushio-Fukai M
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):1991-7. PubMed ID: 16763158
[TBL] [Abstract][Full Text] [Related]
3. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.
Grazia Lampugnani M; Zanetti A; Corada M; Takahashi T; Balconi G; Breviario F; Orsenigo F; Cattelino A; Kemler R; Daniel TO; Dejana E
J Cell Biol; 2003 May; 161(4):793-804. PubMed ID: 12771128
[TBL] [Abstract][Full Text] [Related]
4. Adherens junctions in endothelial cells regulate vessel maintenance and angiogenesis.
Lampugnani MG; Dejana E
Thromb Res; 2007; 120 Suppl 2():S1-6. PubMed ID: 18023702
[TBL] [Abstract][Full Text] [Related]
5. Endothelial cadherins and tumor angiogenesis.
Cavallaro U; Liebner S; Dejana E
Exp Cell Res; 2006 Mar; 312(5):659-67. PubMed ID: 16256984
[TBL] [Abstract][Full Text] [Related]
6. Aberrant association between vascular endothelial growth factor receptor-2 and VE-cadherin in response to vascular endothelial growth factor-a in Shb-deficient lung endothelial cells.
Zang G; Christoffersson G; Tian G; Harun-Or-Rashid M; Vågesjö E; Phillipson M; Barg S; Tengholm A; Welsh M
Cell Signal; 2013 Jan; 25(1):85-92. PubMed ID: 23000345
[TBL] [Abstract][Full Text] [Related]
7. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt.
Nishi J; Minamino T; Miyauchi H; Nojima A; Tateno K; Okada S; Orimo M; Moriya J; Fong GH; Sunagawa K; Shibuya M; Komuro I
Circ Res; 2008 Aug; 103(3):261-8. PubMed ID: 18583712
[TBL] [Abstract][Full Text] [Related]
9. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
[TBL] [Abstract][Full Text] [Related]
10. The molecular organization of endothelial junctions and their functional role in vascular morphogenesis and permeability.
Dejana E; Lampugnani MG; Martinez-Estrada O; Bazzoni G
Int J Dev Biol; 2000; 44(6):743-8. PubMed ID: 11061439
[TBL] [Abstract][Full Text] [Related]
11. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
Schäfer R; Abraham D; Paulus P; Blumer R; Grimm M; Wojta J; Aharinejad S
Circulation; 2003 Sep; 108(13):1585-91. PubMed ID: 12963640
[TBL] [Abstract][Full Text] [Related]
12. Role of cadherins in the transendothelial migration of melanoma cells in culture.
Sandig M; Voura EB; Kalnins VI; Siu CH
Cell Motil Cytoskeleton; 1997; 38(4):351-64. PubMed ID: 9415377
[TBL] [Abstract][Full Text] [Related]
13. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo.
Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J
J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
[TBL] [Abstract][Full Text] [Related]
15. Hydrostatic pressure influences morphology and expression of VE-cadherin of vascular endothelial cells.
Ohashi T; Sugaya Y; Sakamoto N; Sato M
J Biomech; 2007; 40(11):2399-405. PubMed ID: 17261311
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of vascular endothelial growth factor receptors (VEGFR) revealed by RNA interference: interactions of VEGFR-1 and VEGFR-2 in endothelial cell signaling.
Kou R; SenBanerjee S; Jain MK; Michel T
Biochemistry; 2005 Nov; 44(45):15064-73. PubMed ID: 16274253
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor modulates vascular endothelial-cadherin expression in human endothelial cells.
Martin TA; Mansel R; Jiang WG
Clin Cancer Res; 2001 Mar; 7(3):734-7. PubMed ID: 11297270
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
19. Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling.
Rolny C; Lu L; Agren N; Nilsson I; Roe C; Webb GC; Welsh M
Exp Cell Res; 2005 Aug; 308(2):381-93. PubMed ID: 15919073
[TBL] [Abstract][Full Text] [Related]
20. ETS1 lowers capillary endothelial cell density at confluence and induces the expression of VE-cadherin.
Lelièvre E; Mattot V; Huber P; Vandenbunder B; Soncin F
Oncogene; 2000 May; 19(20):2438-46. PubMed ID: 10828886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
